vs
Side-by-side financial comparison of DENNY'S Corp (DENN) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
DENNY'S Corp is the larger business by last-quarter revenue ($113.2M vs $70.6M, roughly 1.6× Viridian Therapeutics, Inc.\DE). DENNY'S Corp runs the higher net margin — 0.6% vs -49.0%, a 49.6% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 1.3%). DENNY'S Corp produced more free cash flow last quarter ($16.0M vs $-84.7M).
Denny's is an American table service diner-style restaurant chain. It operates over 1,400 restaurants in the United States, Canada, México, Puerto Rico, and several other international locations.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
DENN vs VRDN — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $113.2M | $70.6M |
| Net Profit | $632.0K | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 9.2% | -56.7% |
| Net Margin | 0.6% | -49.0% |
| Revenue YoY | 1.3% | 81958.1% |
| Net Profit YoY | -90.3% | 54.9% |
| EPS (diluted) | $0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $113.2M | $70.6M | ||
| Q2 25 | $117.7M | — | ||
| Q1 25 | $111.6M | — | ||
| Q4 24 | $114.7M | — | ||
| Q3 24 | $111.8M | — | ||
| Q2 24 | $115.9M | — | ||
| Q1 24 | $110.0M | — | ||
| Q4 23 | $115.4M | — |
| Q3 25 | $632.0K | $-34.6M | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $326.0K | — | ||
| Q4 24 | $6.8M | — | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $4.7M | — | ||
| Q4 23 | $2.9M | — |
| Q3 25 | 9.2% | -56.7% | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 9.1% | — | ||
| Q4 23 | 6.7% | — |
| Q3 25 | 0.6% | -49.0% | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 5.9% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 4.3% | — | ||
| Q4 23 | 2.5% | — |
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.05 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | $0.13 | — | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.09 | — | ||
| Q4 23 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-32.7M | $503.0M |
| Total Assets | $502.9M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $100.0K | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $2.8M | — | ||
| Q4 23 | $100.0K | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $270.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $264.6M | — |
| Q3 25 | $-32.7M | $503.0M | ||
| Q2 25 | $-34.6M | — | ||
| Q1 25 | $-36.4M | — | ||
| Q4 24 | $-34.0M | — | ||
| Q3 24 | $-54.5M | — | ||
| Q2 24 | $-53.2M | — | ||
| Q1 24 | $-55.7M | — | ||
| Q4 23 | $-62.7M | — |
| Q3 25 | $502.9M | $577.1M | ||
| Q2 25 | $491.1M | — | ||
| Q1 25 | $488.1M | — | ||
| Q4 24 | $496.3M | — | ||
| Q3 24 | $461.6M | — | ||
| Q2 24 | $459.9M | — | ||
| Q1 24 | $460.4M | — | ||
| Q4 23 | $464.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.0M | $-84.6M |
| Free Cash FlowOCF − Capex | $16.0M | $-84.7M |
| FCF MarginFCF / Revenue | 14.1% | -120.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | 25.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $16.0M | $-84.6M | ||
| Q2 25 | $9.4M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $6.6M | — | ||
| Q2 24 | $14.2M | — | ||
| Q1 24 | $215.0K | — | ||
| Q4 23 | $21.4M | — |
| Q3 25 | $16.0M | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 14.1% | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | 25.28× | — | ||
| Q2 25 | 3.79× | — | ||
| Q1 25 | 15.38× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 3.97× | — | ||
| Q1 24 | 0.05× | — | ||
| Q4 23 | 7.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DENN
| Franchisor Owned Outlet | $57.4M | 51% |
| Royalty | $27.7M | 25% |
| Advertising | $18.6M | 16% |
| Occupancy | $7.7M | 7% |
| Initial And Other Fees | $1.7M | 1% |
VRDN
Segment breakdown not available.
